Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 11 years of Goodwill data on record, last reported at $3.4 million in Q2 2025.

  • For Q2 2025, Goodwill changed N/A year-over-year to $3.4 million; the TTM value through Jun 2025 reached $3.4 million, changed N/A, while the annual FY2023 figure was $3.2 million, 2.88% up from the prior year.
  • Goodwill reached $3.4 million in Q2 2025 per AMPH's latest filing, up from $3.2 million in the prior quarter.
  • Across five years, Goodwill topped out at $3.8 million in Q1 2021 and bottomed at $2.9 million in Q3 2022.
  • Average Goodwill over 4 years is $3.3 million, with a median of $3.2 million recorded in 2023.
  • Peak YoY movement for Goodwill: fell 15.91% in 2021, then rose 2.88% in 2023.
  • A 4-year view of Goodwill shows it stood at $3.3 million in 2021, then fell by 5.64% to $3.1 million in 2022, then rose by 2.88% to $3.2 million in 2023, then grew by 5.63% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $3.4 million in Q2 2025, $3.2 million in Q4 2023, and $3.1 million in Q4 2022.